Your prediction
Novozymes A/S B Stock
A loss of -1.960% shows a downward development for Novozymes A/S B.
For the coming years our community has positive and negative things to say abot the Novozymes A/S B stock. Criterium "Return on equity" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | -1.960% | -2.597% | -5.869% | -4.530% | -6.866% | 8.765% | -0.157% |
| Solvay S.A. A | -1.840% | -3.733% | 2.916% | -14.203% | -1.830% | -74.876% | -72.925% |
| FMC Corp. | -7.090% | -4.928% | -15.971% | -68.357% | -1.026% | -90.497% | -86.583% |
| Covestro AG | -0.300% | -0.329% | 0.066% | 3.373% | 0.831% | 46.854% | 0.464% |
